Stories 31 - 40 for Prostatic

Prostate-sparing cystectomy (PSC) for bladder cancer, a procedure aimed at preserving sexual function by leaving the prostate, seminal vesicles, ...

This applies to 4 mg and 8 mg hard-capsule doses respectively for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). ...

Blockade of these receptors causes smooth muscle in the prostate, urinary bladder base and neck, prostatic capsule and prostatic urethra to relax, ...

A non-cancerous condition called BPH (benign prostatic hyperplasia) is far more common, affecting up to four in 10 men over 65. ...

... partially hiding mothers as they voided children on the grass or grandfathers easing prostatic pressure on the hedgerows of Co Meath and Co Louth. ...

Though SARMs offer promise for the treatment of a number of diseases -- including osteoporosis, sarcopenia, benign prostatic hyperplasia and cancer cachexia ...

Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC). Dendreon Corporation is a biotechnology ...

LONDON, Nov. 19, 2009-On 19 November 2009 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion** to recommend the variation ...

LONDON, Nov. 19, 2009-On 19 November 2009 the Committee for Medicinal Products for Human Use (CHMP), having considered new information, adopted a positive ...